Research location
Mendoza
Mendoza Province, Argentina
Advertisement
Research activity in Mendoza
Mendoza Province, ArgentinaCureCurrent currently publishes aggregate city-level research activity for this location: 52 trials and 62 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Mendoza
52 linked trials · page 1 of 2A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)NCT07646587 · 2026-06-02 · 1 site observation
RECRUITING
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)NCT07359846 · 2026-01-20 · 1 site observation
RECRUITING
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaNCT06977581 · 2025-05-20 · 2 site observations
RECRUITING
Clinical Trial with Cannabidiol (Kanbis®) for Parkinson Disease SymptomsNCT06629389 · 2024-11-28 · 1 site observation
RECRUITING
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With AsthmaNCT05562466 · 2023-05-11 · 1 site observation
RECRUITING
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPDNCT06981078 · 2025-07-02 · 1 site observation
ACTIVE_NOT_RECRUITING
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)NCT06966479 · 2025-05-21 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)NCT06196879 · 2024-02-27 · 1 site observation
COMPLETED
A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's DiseaseNCT05744401 · 2023-01-04 · 1 site observation
TERMINATED
Long-term Safety Extension Study of OLZ/SAM in Pediatric SubjectsNCT04987229 · 2021-10-22 · 1 site observation
ENROLLING_BY_INVITATION
Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderNCT05061706 · 2021-09-30 · 1 site observation
COMPLETED
A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPDNCT01860066 · 2013-12-01 · 2 site observations
WITHDRAWN
QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations)NCT01782326 · 2013-07-01 · 2 site observations
COMPLETED
A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyNCT01714713 · 2013-06-01 · 1 site observation
COMPLETED
Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow LimitationNCT01610037 · 2012-10-01 · 2 site observations
COMPLETED
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyNCT01716975 · 2012-10-01 · 1 site observation
COMPLETED
Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyNCT01714661 · 2012-10-01 · 1 site observation
COMPLETED
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseNCT01609582 · 2012-06-01 · 1 site observation
TERMINATED
Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.NCT01525199 · 2012-05-01 · 1 site observation
COMPLETED
Dose-ranging Study of Vilanterol (VI) Inhalation Powder in ChildrenNCT01573767 · 2012-04-01 · 1 site observation
COMPLETED
Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.)NCT01555138 · 2012-02-01 · 2 site observations
COMPLETED
Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 DiabetesNCT01456195 · 2011-11-01 · 1 site observation
COMPLETED
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)NCT01443845 · 2011-09-30 · 1 site observation
COMPLETED
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and AdolescentsNCT01431950 · 2011-09-01 · 1 site observation
COMPLETED
Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major DepressionNCT01361555 · 2011-08-01 · 1 site observation
TERMINATED
Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major DepressionNCT01369095 · 2011-07-01 · 1 site observation
COMPLETED
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary DiseaseNCT01316913 · 2011-03-01 · 1 site observation
COMPLETED
Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic PatientsNCT01197794 · 2010-10-01 · 1 site observation
COMPLETED
Immunotherapy With Racotumomab in Advanced Lung CancerNCT01460472 · 2010-09-01 · 1 site observation
UNKNOWN
A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.NCT01197508 · 2010-09-01 · 1 site observation
COMPLETED
HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and AdolescentsNCT01147848 · 2010-06-01 · 1 site observation
COMPLETED
Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) ExacerbationsNCT01120691 · 2010-04-01 · 2 site observations
COMPLETED
Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and HypertensionNCT01031680 · 2010-02-01 · 1 site observation
COMPLETED
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart FailureNCT01035255 · 2009-12-01 · 3 site observations
TERMINATED
Parameters of Acceptability, Compliance and Efficacy of Fulvestrant in Post-menopausal Patients With Advance Breast CancerNCT00878930 · 2009-04-01 · 1 site observation
COMPLETED
Exacerbation StudyNCT00845728 · 2009-03-01 · 1 site observation
COMPLETED
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With SchizophreniaNCT00705783 · 2008-07-01 · 2 site observations
COMPLETED
A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT00606684 · 2008-02-01 · 1 site observation
COMPLETED
Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma.NCT00600171 · 2007-12-01 · 1 site observation
COMPLETED
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With AsthmaNCT00452348 · 2007-05-01 · 1 site observation
COMPLETED
A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPDNCT00419744 · 2007-01-01 · 1 site observation
COMPLETED
A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. MetforminNCT00386100 · 2006-10-01 · 1 site observation
COMPLETED
A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive TumorsNCT00373425 · 2006-09-01 · 1 site observation
COMPLETED
Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive DisorderNCT00388973 · 2006-09-01 · 1 site observation
COMPLETED
A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and ExerciseNCT00327015 · 2006-05-01 · 1 site observation
COMPLETED
A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy AloneNCT00295633 · 2006-03-01 · 1 site observation
COMPLETED
A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's DiseaseNCT00322153 · 2005-06-01 · 2 site observations
COMPLETED
PPAR-COMBO With SulfonylureaNCT00162175 · 2003-07-01 · 1 site observation
COMPLETED
PPAR - Combination With MetforminNCT00162240 · 2003-06-01 · 1 site observation
COMPLETED
Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)NCT00095238 · 2002-06-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.